SCHEMBL8254322

SCHEMBL8254322

OCC(CO)O[C@@H]1OC(CO)[C@@H](O)C(O)C1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD3 O94806 1/20 0.56
PRKCG P05129 1/20 0.56
PRKCB P05771 1/20 0.56
PRKCA P17252 1/20 0.56
PRKCH P24723 1/20 0.56
PRKCI P41743 1/20 0.56
PRKCE Q02156 1/20 0.56
PRKCQ Q04759 1/20 0.56
PRKCZ Q05513 1/20 0.56
PRKCD Q05655 1/20 0.56
PRKD1 Q15139 1/20 0.56
CD209 Q9NNX6 3/20 0.51
SYNJ2 O15056 2/20 0.50
GAA P10253 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ABL1 P00519 1/20 0.50
ALPL P05186 1/20 0.50
POLB P06746 1/20 0.50
ALPI P09923 1/20 0.50
MAPT P10636 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16186721 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL18328428 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL1923753 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL14217500 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL3924682 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL2300084 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL13851827 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL3516599 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL12030336 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL5545675 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210213039-A1 COMPOSITION CONTAINING ECTOINE OR HYDROXYECTOINE AS AN ACTIVE SUBSTANCE FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE BITOP AG (DE) 2021-07-15 US disclosed
EP-3536351-A1 COMPOSITION FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE Bitop AG (DE) 2019-09-11 EP disclosed
US-20180015017-A1 USE OF GLUCOSYLGLYCEROL BITOP AG (DE) 2018-01-18 US disclosed
US-9867767-B2 Use of glucosylglycerol BITOP AG (DE) 2018-01-16 US disclosed
US-20170189435-A1 COMPOSITION CONTAINING ECTOINE OR HYDROXYECTOINE AS AN ACTIVE SUBSTANCE FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE BITOP AG (DE) 2017-07-06 US disclosed
EP-3153185-A1 COMPOSITION FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE Bitop AG (DE) 2017-04-12 EP disclosed
EP-2094234-B1 COSMETIC FORMULATION CONTAINING GLUCOSYL GLYCERIDES AND UREA BEIERSDORF AG (DE) 2013-07-10 EP disclosed
EP-1885329-B1 COSMETIC PREPARATIONS CONTAINING GLUCOSYL GLYCERIDES AND AN ACRYLAMIDOMETHYL PROPYLSULPHONIC ACID - VP - COPOLYMER BEIERSDORF AG (DE) 2012-11-21 EP disclosed
EP-2255781-B1 Cosmetic preparation containing glucosyl glycerides and powder BEIERSDORF AG (DE) 2012-08-22 EP disclosed
WO-2012084419-A2 ACTIVE SUBSTANCE COMBINATIONS OF GLUCOSYL GLYCERIDES AND ONE OR MORE SUBSTANCES ACTIVE AGAINST DANDRUFF BEIERSDORF AG (DE) 2012-06-28 WO disclosed
US-20100047197-A1 COSMETIC FORMULATION CONTANING GLUCOSYL GLYCERIDES AND UREA BEIERSDORF AG (DE) 2010-02-25 US disclosed
WO-2010020424-A2 USE OF GLUCOSYLGLYCEROL BITOP AG (DE) 2010-02-25 WO disclosed
US-20090137497-A1 ACTIVE INGREDIENT COMBINATIONS OF GLUCOSYL GLYCERIDES AND CREATINE AND/OR CREATININE BEIERSDORF AG (DE) 2009-05-28 US disclosed
US-20090130223-A1 COSMETIC PREPARATION WITH AQUAPORIN STIMULATORS AND THE USE THEREOF BEIERSDORF AG (DE) 2009-05-21 US disclosed
WO-2008058681-A1 COSMETIC FORMULATION CONTAINING GLUCOSYL GLYCERIDES AND UREA BEIERSDORF AG (DE) 2008-05-22 WO disclosed
WO-2008058680-A1 COSMETIC FORMULATION CONTAINING GLUCOSYL GLYCERIDES AND SKIN LIGHTENING AGENTS BEIERSDORF AG (DE) 2008-05-22 WO disclosed
WO-2008058715-A1 COSMETIC FORMULATION CONTAINING GLUCOSYL GLYCERIDES AND CATIONIC EMULSIFIERS BEIERSDORF AG (DE) 2008-05-22 WO disclosed
WO-2008058719-A1 COSMETIC FORMULATION HAVING GLUCOSYL GLYCERIDES AND SCENTED SUBSTANCES BEIERSDORF AG (DE) 2008-05-22 WO disclosed
EP-1923045-A1 Cosmetic preparation containing glucosyl glycerides and powder Beiersdorf Aktiengesellschaft (DE) 2008-05-21 EP disclosed
WO-2006122668-A1 ACTIVE INGREDIENT COMBINATIONS OF GLUCOSYL GLYCERIDES AND CREATINE AND/OR CREATININE BEIERSDORF AG (DE) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210213039-A1 COMPOSITION CONTAINING ECTOINE OR HYDROXYECTOINE AS AN ACTIVE SUBSTANCE FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE ENPP3, UGCG, ENPP1 PRKD3 1317/4885PRKCG 745/4885PRKCB 833/4885
US-20090130223-A1 COSMETIC PREPARATION WITH AQUAPORIN STIMULATORS AND THE USE THEREOF AQP1, AQP3, AQP4 PRKD3 1299/4885PRKCG 358/4885PRKCB 1320/4885
US-20100047197-A1 COSMETIC FORMULATION CONTANING GLUCOSYL GLYCERIDES AND UREA UGCG, UGGT1, GLA PRKD3 4320/4885PRKCG 1173/4885PRKCB 2321/4885
US-20180015017-A1 USE OF GLUCOSYLGLYCEROL UGCG, GBA3, GLB1 PRKD3 1703/4885PRKCG 822/4885PRKCB 1559/4885
US-20090137497-A1 ACTIVE INGREDIENT COMBINATIONS OF GLUCOSYL GLYCERIDES AND CREATINE AND/OR CREATININE GK, GLA, GRHPR PRKD3 2014/4885PRKCG 368/4885PRKCB 544/4885
US-20170189435-A1 COMPOSITION CONTAINING ECTOINE OR HYDROXYECTOINE AS AN ACTIVE SUBSTANCE FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE ENPP3, UGCG, ENPP1 PRKD3 1317/4885PRKCG 745/4885PRKCB 833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.